Home > Insider Trading > Filing (0001209191-10-058460)

Filing Details

Accession Number:: 0001209191-10-058460
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-12-03 20:59:31
Reporting Period:: 2010-12-01

Filing Date:: 2010-12-03
Accepted Time:: 2010-12-03 20:59:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
858803	Avanir Pharmaceuticals Inc.	AVNR	Pharmaceutical Preparations (2834)	330314804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1280154	Christine Ocampo	101 Enterprise, Suite 300 Aliso Viejo CA 92656	Vice President, Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-12-01	11,250	$0.00	53,232	No	4	A	Direct
Common Stock	Acquisiton	2010-12-02	24,000	$1.74	77,232	No	4	M	Direct
Common Stock	Disposition	2010-12-02	24,000	$4.15	53,232	No	4	S	Direct
Common Stock	Acquisiton	2010-12-03	14,350	$1.74	67,582	No	4	M	Direct
Common Stock	Disposition	2010-12-03	14,350	$4.03	53,232	No	4	S	Direct
Common Stock	Acquisiton	2010-12-03	9,000	$0.88	62,232	No	4	M	Direct
Common Stock	Disposition	2010-12-03	9,000	$4.03	53,232	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2010-12-01	72,500	$0.00	72,500	$4.18
Common Stock	Stock Option (right to buy)	Disposition	2010-12-02	24,000	$0.00	24,000	$1.74
Common Stock	Stock Option (right to buy)	Disposition	2010-12-03	14,350	$0.00	14,350	$1.74
Common Stock	Stock Option (right to buy)	Disposition	2010-12-03	9,000	$0.00	9,000	$0.88

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
72,500	2020-12-01	No	4	A	Direct
129,400	2019-11-27	No	4	M	Direct
115,050	2019-11-27	No	4	M	Direct
39,000	2018-07-25	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	11,900	Indirect	By spouse

Footnotes

Represents shares underlying Restricted Stock Units granted under the Issuer's 2005 Equity Incentive Plan that vest upon the satisfaction of certain performance milestones as follows: 50% of the underlying shares shall vest one year from achievement of the milestones and the remaining 50% of the underlying shares shall vest two years from achievement of the milestones.
Not applicable.
Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.
These shares are held by the Reporting Person's spouse, which are deemed beneficially owned by the Reporting Person.
The option shall vest with respect to one-quarter of the underlying shares upon the first anniversary of December 1, 2010, and then with respect to the remaining shares quarterly thereafter over the next three years.
The option vests with respect to one-quarter of the underlying shares upon the first anniversary of November 27, 2009, and then with respect to the remaining shares quarterly thereafter over the next three years.
On July 25, 2008, the reporting person was granted an option to purchase up to 55,200 shares of common stock of the Issuer. The option vests and becomes exercisable following the achievement of certain performance goals relating to the clinical development of Zenvia, as follows: 55,200 shares will vest if the performance goals are met on or before December 31, 2008; 51,600 shares will vest if the performance goals are met between January 1 and February 15, 2009; 48,000 shares will vest if the performance goals are met between February 16 and March 31, 2009; 33,600 shares will vest if the performance goals are met between April 1 and June 30, 2009; and none of the shares will vest if the performance goals are met on or after July 1, 2009. Because the performance goals were met between February 16 and March 31, 2009, the reporting person was granted an option to purchase up to 48,000 shares of common stock of the Issuer.
The option vested with respect to 6.25% of the underlying shares upon achievement of the performance goals and continues to vest with respect to 6.25% of the underlying shares on a quarterly basis over 15 quarters from the date of achievement of the performance goals.